SCHEMBL8694166

SCHEMBL8694166

CCOC(=O)C=CC(=O)C(C)(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 4/20 0.59
MAPT P10636 8/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
MAPK1 P28482 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 4/20 0.44
MDM2 Q00987 2/20 0.44
ATM Q13315 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
ALDH1A1 P00352 3/20 0.40
TTR P02766 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22485788 1.00 HCAR2 (0.59) HCAR2MAPTMEN1NPC1MAPK1
SCHEMBL8694161 1.00 HCAR2 (0.59) HCAR2MAPTMEN1NPC1MAPK1
Diethyl Maleate SCHEMBL2015895 0.83 HCAR2 (0.80) HCAR2MAPTLMNAMDM2ATM
Diethyl Maleate SCHEMBL43033 0.83 HCAR2 (0.80) HCAR2MAPTLMNAMDM2ATM
Diethyl Maleate SCHEMBL27966383 0.83 HCAR2 (0.80) HCAR2MAPTLMNAMDM2ATM
Diethyl Maleate SCHEMBL2015896 0.83 HCAR2 (0.80) HCAR2MAPTLMNAMDM2ATM
Diethyl Maleate SCHEMBL42602 0.83 HCAR2 (0.80) HCAR2MAPTLMNAMDM2ATM
SCHEMBL18406963 0.83 HCAR2 (0.62) HCAR2MAPTMEN1NPC1MAPK1
Diethyl Maleate SCHEMBL60423 0.83 HCAR2 (0.80) HCAR2MAPTLMNAMDM2ATM
Diethyl Maleate SCHEMBL135447 0.81 HCAR2 (0.76) HCAR2MAPTLMNAMDM2ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5846941-A Isosteric antiherpes peptide derivatives II BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 1998-12-08 US disclosed
EP-0560267-B1 Isosteric antiherpes peptide derivatives BOEHRINGER INGELHEIM CA LTD (CA) 1998-08-19 EP disclosed
EP-0767671-A1 METHOD OF COMBATING ACYCLOVIR-RESISTANT HERPES SIMPLEX VIRAL INFECTIONS BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 1997-04-16 EP disclosed
US-5574015-A Isosteric antiherpes peptide derivatives BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1996-11-12 US disclosed
CN-1126438-A Method of combating acyclovir-resistant herpes simplex viral infections BIO MEGA BOEHRINGER INGELHEIM (CA) 1996-07-10 CN disclosed
WO-1994025046-A1 METHOD OF COMBATING ACYCLOVIR-RESISTANT HERPES SIMPLEX VIRAL INFECTIONS BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1994-11-10 WO disclosed
WO-1993018056-A1 ISOSTERIC ANTIHERPES PEPTIDE DERIVATIVES BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-16 WO disclosed
EP-0560267-A1 Isosteric antiherpes peptide derivatives BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-15 EP disclosed